BioCircuit Technologies Receives FDA 510(k)

The product is the first FDA-cleared, sutureless solution for surgical repair of transected nerves.

Sutureless solution for surgical repair of transected nerves (Image credit: GlobeNewsWire)

BioCircuit Technologies, a National Institutes of Health (NIH)-founded medical device company focused on tissue repair and neuromodulation, announced today it has received FDA 510(k) clearance for its nerve repair device, Nerve Tape®. The product’s patented design is the first FDA-cleared, sutureless solution for surgical repair of transected nerves.

“The development and clearance of NerveTape represent a significant advancement in the treatment of nerve injuries,” said Jonathan Isaacs, MD, Professor and Chair, Division of Hand Surgery, Virginia Commonwealth University Medical Center. “This product has the potential to offer surgeons a faster, simpler method for achieving a precise, reliable repair of injured nerves. As a co-inventor with several years of experience using the device in animal models, I look forward to having NerveTape available for clinical use.”

“We are very pleased to have completed this critical milestone on our path towards providing a new solution for the treatment of peripheral nerve injuries,” said Michelle Jarrard, CEO ofBioCircuit Technologies. “As BioCircuit’s first FDA-cleared medical device, Nerve Tape exemplifies our commitment to equipping surgeons with powerful, practical tools to improve the treatment of injuries, and we are excited to be entering the commercial phase of development as we prepare to bring this solution to market.”  

Nerve Tape was developed in partnership with the Orthopedic Microsurgery Laboratory at Virginia Commonwealth University, Richmond, VA.

As previously announced, BioCircuit is working with supply partners in preparation for the launch of Nerve Tape in the United States. The Company anticipates the product will be available for first human use in 2023.

About BioCircuit Technologies

Based in Atlanta, GA, BioCircuitTechnologies develops and commercializes medical devices for tissue repair and neuromodulation. Designed for ease of use and reliability, these devices enhance therapeutic targeting, diagnostic precision, and surgical consistency for improved patient outcomes.

BioCircuit has received generous funding from numerous NIH grants. In addition to ongoing grant support, BioCircuit has attracted private financing, including investment from the GRA Venture Fund, Masters Capital, and Alsora Capital.

Jürgen Thalmayer
September 21, 2022

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Abbott Receives FDA Clearance for Two CGMs

Abbott received FDA clearances for two new over-the-counter CGM systems.

Qualcomm Launches $200M Investment Fund to Back Companies Building the 5G Ecosystem

Wireless tech company Qualcomm announced the launch of the Qualcomm Ventures 5G Ecosystem...

UMich Researchers Develop Japanese Kirigami Influenced Sensor Patch for Injury Recovery and Athlete Training

A researcher from the University of Michigan (UMich) has developed a wearable sensor patch to...

Exactech Acquires Medical Wearables Pioneer Muvr To Help Surgeons Better With Joint Replacement Patients

Exactech, a developer and producer of innovative implants, instrumentation and smart technologies...
Discover more